Skip Navigation
U.S. Department of Health & Human Services Logo
HHS URL Link
OER Logo   OER Public Websites Archive   Archive  
This website contains archived materials provided for historical reference purposes only.
The content and links are no longer maintained and may be outdated.
 
Related Archives         
ARCHIVED - NIH Clinical Trial Planning Grant Program (R34) (PA-06-363)
Contacts, Submission Dates and Special Interests/Instructions
Release Date: April 21, 2006
Expiration Date: May 8, 2009


Note: See replacement announcement PA-09-186 and updated Contacts List.



Introduction

Introduced in the Fall of 2003, the NIH Clinical Trial Planning Grant Program was developed to provide support for the development of Phase III clinical trials. This program supports the establishment of the research team, the development of tools for data management and oversight of the research, the definition of recruitment strategies, and the finalization of the protocol and other essential elements of the study included in a manual of operations/procedures. The Clinical Trial Planning Grant is not designed for the collection of preliminary data or the conduct of pilot studies to support the rationale for a clinical trial.

Some of the non-participating ICs may solicit R34 applications using specific Funding Opportunity Announcements (FOAs) in order to meet specific programmatic needs. In some cases those announcements may specify different application characteristics, review criteria, and receipt dates. All such announcements will be published in the NIH Guide for Grants and Contracts at http://grants.nih.gov/grants/guide/index.html. The FOA for investigator-initiated R34 applications can be found at PA-06-363 and articulates the policies and procedures that apply to this program.

R34 Participating/Non-Participating Institutes and Centers

  • NIH Institutes and Centers that DO NOT accept R34 applications in response to this Parent R34 Announcement but ONLY accept Clinical Trial Planning Grant (R34) applications in response to their specific funding opportunity announcements: NCCAM, NIAID, NIBIB, NIDDK, NCI, NIDCR, NIEHS, NIGMS, NHLBI, NHGRI, NIMH, NLM, and NCRR.

NIH Institute and Center Contacts and Scientific Research Areas of Interest

NIH Institute/Center

Scientific/Research Contact

Financial or Grants Management Contact

National Institute on Aging (NIA)

Ms. Joanna Badinelli
Phone: 301-435-3046
FAX: 301-480-1066
Email:  BadinelJ@mail.nih.gov
Linda Whipp
Phone: 301-496-1472
FAX: 301-402-3672
Email:  whippL@mail.nih.gov
The National Institute on Aging (NIA) will accept investigator-initiated R34 applications for all program areas supported by the Institute.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

 

Margaret E. Mattson, Ph.D.
Phone: 301-443-0638
FAX: 301-443-8774
Email: mmattson@mail.nih.gov

Judy Fox
Phone: 301-443-4704
FAX: 301-443-3891
Email:  jfox@mail.nih.gov

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) will accept R34 applications in response to a Request for Applications (RFA), or when NIAAA has specifically agreed to accept an application after discussion between the potential applicant and program staff.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

 

Madeline Turkeltaub, RN,PhD,CRNP,FAAN
Deputy Director, Extramural Program
NIAMS
6701 Democracy Blvd.  Suite 800
Bethesda, MD  20892
Phone:  301-451-5888
FAX:     301-480-4543
Email: mturkeltaub@mail.nih.gov

Melinda B. Nelson 
Phone: 301-594-3535
FAX: 301-480-5450 
Email:  mn23z@nih.gov

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will accept R34 applications for all program areas supported by the Institute.

For information regarding specific scientific programs and contacts, see http://www.niams.nih.gov/rtac/index.htm.

National Institute of Child Health and Human Development (NICHD)

 

Eugene G. Hayunga, Ph.D.
Phone: 301-435-6856
FAX: 301-480-2400
Email:  ehayunga@mail.nih.gov
John Chris Robey
Phone: 301-435-6996
FAX: 301-451-5510
Email:  robeyj@mail.nih.gov

The National Institute of Child Health and Human Development (NICHD) accepts R34 applications for planning of Phase III clinical trials in all program areas supported by the Institute.

National Institute on Deafness and Other Communication Disorders (NIDCD)

Ling Chin, MD, MPH
Phone: 301-435-4085
FAX:   301-402-6251
Email:  lchin@nidcd.nih.gov

For a list of scientific staff, also see Staff Contacts.
Christopher Myers
Phone: 301-435-0713
FAX: 301-402-1758
Email:  myersc@mail.nih.gov

The National Institute on Deafness and Other Communication Disorders (NIDCD) uses the R34 mechanism to support planning of all investigator-initiated clinical trials when NIDCD has specifically agreed to accept an application after discussion between the potential applicant and program staff.

National Institute on Drug Abuse (NIDA)

Teresa Levitin, Ph.D.
Phone: 301-443-2755
FAX: 301-443-0538
Email:  TL25u@nih.gov

Diana Haikalis
Phone: 301-443-6710
FAX: 301-594-6849
Email:  dhaikali@nida.nih.gov

The National Institute on Drug Abuse (NIDA) The National Institute on Drug Abuse (NIDA) will accept investigator-initiated R34 applications for all program areas supported by the Institute.

National Institute of Neurological Disorders and Stroke (NINDS)

Scott Janis, Ph.D.
Phone: 301-496-9135
FAX: 301-480-1080
Email: sj151t@nih.gov

James E. Washington, M.Ed.
Phone: 301-496-7449
FAX: 301-451-5635
Email:  washingj@ninds.nih.gov

The National Institute of Neurological Disorders and Stroke (NINDS) will accept investigator-initiated R34 applications for all program areas supported by the Institute. See NINDS Overview

National Eye Institute (NEI)

Dr. Donald F. Everett          
Email: dfe@nei.nih.gov       

Dr. Natalie Kurinij
Email: kurinij@nei.nih.gov

Dr. Maryann Redford
Email: maryann.redford@nei.nih.gov

Phone for all: 301-451-2020          
FAX for all: 301-402-0528   

William Darby
Phone: 301-435-8179
FAX: 301-496-9997
Email: darbyw@mail.nih.gov

The National Eye Institute (NEI) accepts investigator-initiated R34 applications for all program areas supported by the Institute. The Planning Grant is used to support the development of a detailed MOP and may include preliminary studies to refine study procedures or to document recruitment potential. Applicants may request direct costs up to $150,000 per year for up to two years of support.

Office of Rare Diseases (ORD)

Dr. Giovanna Spinella
Phone: (301-496-0139,
FAX:
Email: SpinellG@mail.nih.gov

 

Office of Dietary Supplements (ODS)

Dr. Rebecca Costello
Phone: 301-435-3605
FAX: 301 480-1845
Email: CostellB@od.nih.gov

 
The Office of Dietary Supplements (ODS) is a potential source of co-funding to support R34 applications for planning of clinical trials relevant to dietary supplements.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

 

Sanford Garfield, Ph.D (for behavioral research)
Phone: 301-594-8803
FAX:  301-480-3503
E-mail:  sg50o@nih.gov   

Barbara Linder, M.D., Ph.D. (for pediatric medical research)
Phone: 301-594-0021
FAX: 301-480-3503
E-mail:  bl99n@nih.gov
 
Myrlene Staten, M.D. (for adult medical research)
Phone: 301-402-7886
FAX:  301-480-3503
E-mail:  ms808k@nih.gov

Robert Kuczmarski (for obesity research)
Phone: 301-451-8354
FAX:  301-480-8300
E-mail:  rk191r@nih.gov

 

See PAR-06-358

National Institute of Mental Health (NIMH)

Joel Sherrill, Ph.D.
Division of Services and Intervention Research
Phone:  301-443-2477
FAX:  301-594-6784
Email: jsherril@mail.nih.gov

Dianne Rausch, Ph.D.
Division of AIDS and Health and Behavior Research
Phone:  301-443-6100
FAX:  301-443-9719
Email: drausch@mail.nih.gov

Rebecca Claycamp, M.S., CRA
Phone: 301-443-2811
FAX: 301-443-6885
Email: rclaycam@mail.nih.gov
See PAR-06-248

Archive web This web page is archived and provided for historical reference purposes only. The content and links are no longer maintained and may be outdated. See the Archive Home Page for more details about archived files.